Free Trial
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free BKYI Stock Alerts

BIO-key International (BKYI) Competitors

BIO-key International logo
$2.84 -0.07 (-2.37%)
As of 02:18 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

BKYI vs. AUID, BTQ, MSFT, ORCL, and PANW

Should you buy BIO-key International stock or one of its competitors? BIO-key International's main competitors and comparable companies include authID (AUID), BTQ Technologies (BTQ), Microsoft (MSFT), Oracle (ORCL), and Palo Alto Networks (PANW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does BIO-key International compare to authID?

authID (NASDAQ:AUID) and BIO-key International (NASDAQ:BKYI) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

BIO-key International has a net margin of -50.01% compared to authID's net margin of -934.06%. BIO-key International's return on equity of -67.31% beat authID's return on equity.

Company Net Margins Return on Equity Return on Assets
authID-934.06% -297.48% -213.83%
BIO-key International -50.01%-67.31%-40.28%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
authID
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, BIO-key International had 6 more articles in the media than authID. MarketBeat recorded 9 mentions for BIO-key International and 3 mentions for authID. authID's average media sentiment score of 0.38 beat BIO-key International's score of 0.16 indicating that authID is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
authID
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

8.8% of authID shares are owned by institutional investors. Comparatively, 26.5% of BIO-key International shares are owned by institutional investors. 17.4% of authID shares are owned by insiders. Comparatively, 4.0% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

authID has a beta of 1.72, indicating that its share price is 72% more volatile than the broader market. Comparatively, BIO-key International has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

BIO-key International has higher revenue and earnings than authID. BIO-key International is trading at a lower price-to-earnings ratio than authID, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
authID$2.04M2.63-$17.93M-$1.23N/A
BIO-key International$6.70M0.62-$7.16M-$4.11N/A

Summary

BIO-key International beats authID on 8 of the 13 factors compared between the two stocks.

How does BIO-key International compare to BTQ Technologies?

BTQ Technologies (NASDAQ:BTQ) and BIO-key International (NASDAQ:BKYI) are both technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

BTQ Technologies has higher earnings, but lower revenue than BIO-key International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTQ TechnologiesN/AN/AN/AN/AN/A
BIO-key International$6.70M0.62-$7.16M-$4.11N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTQ Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

BTQ Technologies has a net margin of 0.00% compared to BIO-key International's net margin of -50.01%. BTQ Technologies' return on equity of 0.00% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BTQ TechnologiesN/A N/A N/A
BIO-key International -50.01%-67.31%-40.28%

26.5% of BIO-key International shares are owned by institutional investors. 4.0% of BIO-key International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, BIO-key International had 2 more articles in the media than BTQ Technologies. MarketBeat recorded 9 mentions for BIO-key International and 7 mentions for BTQ Technologies. BTQ Technologies' average media sentiment score of 0.55 beat BIO-key International's score of 0.16 indicating that BTQ Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BTQ Technologies
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

BTQ Technologies beats BIO-key International on 6 of the 10 factors compared between the two stocks.

How does BIO-key International compare to Microsoft?

BIO-key International (NASDAQ:BKYI) and Microsoft (NASDAQ:MSFT) are both technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

Microsoft has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Microsoft, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.70M0.62-$7.16M-$4.11N/A
Microsoft$331.84B11.94$133.75B$17.9629.72

Microsoft has a net margin of 40.31% compared to BIO-key International's net margin of -50.01%. Microsoft's return on equity of 31.98% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Microsoft 40.31%31.98%18.70%

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 71.1% of Microsoft shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Comparatively, 0.0% of Microsoft shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

BIO-key International has a beta of 0.5, meaning that its stock price is 50% less volatile than the broader market. Comparatively, Microsoft has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

In the previous week, Microsoft had 358 more articles in the media than BIO-key International. MarketBeat recorded 367 mentions for Microsoft and 9 mentions for BIO-key International. Microsoft's average media sentiment score of 0.90 beat BIO-key International's score of 0.16 indicating that Microsoft is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Microsoft
225 Very Positive mention(s)
41 Positive mention(s)
43 Neutral mention(s)
43 Negative mention(s)
10 Very Negative mention(s)
Positive

Microsoft has a consensus price target of $581.24, indicating a potential upside of 8.91%. Given Microsoft's stronger consensus rating and higher probable upside, analysts clearly believe Microsoft is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Microsoft
2 Sell rating(s)
5 Hold rating(s)
41 Buy rating(s)
0 Strong Buy rating(s)
2.81

Summary

Microsoft beats BIO-key International on 15 of the 16 factors compared between the two stocks.

How does BIO-key International compare to Oracle?

Oracle (NYSE:ORCL) and BIO-key International (NASDAQ:BKYI) are both technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Oracle presently has a consensus target price of $251.72, indicating a potential upside of 92.74%. Given Oracle's stronger consensus rating and higher possible upside, equities analysts plainly believe Oracle is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oracle
1 Sell rating(s)
9 Hold rating(s)
36 Buy rating(s)
1 Strong Buy rating(s)
2.79
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Oracle has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Oracle, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oracle$67.36B5.86$17.09B$6.3820.47
BIO-key International$6.70M0.62-$7.16M-$4.11N/A

42.4% of Oracle shares are owned by institutional investors. Comparatively, 26.5% of BIO-key International shares are owned by institutional investors. 38.4% of Oracle shares are owned by insiders. Comparatively, 4.0% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Oracle has a net margin of 26.36% compared to BIO-key International's net margin of -50.01%. Oracle's return on equity of 48.85% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
Oracle26.36% 48.85% 7.93%
BIO-key International -50.01%-67.31%-40.28%

In the previous week, Oracle had 111 more articles in the media than BIO-key International. MarketBeat recorded 120 mentions for Oracle and 9 mentions for BIO-key International. Oracle's average media sentiment score of 0.63 beat BIO-key International's score of 0.16 indicating that Oracle is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oracle
54 Very Positive mention(s)
27 Positive mention(s)
13 Neutral mention(s)
14 Negative mention(s)
12 Very Negative mention(s)
Positive
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Oracle has a beta of 1.78, meaning that its share price is 78% more volatile than the broader market. Comparatively, BIO-key International has a beta of 0.5, meaning that its share price is 50% less volatile than the broader market.

Summary

Oracle beats BIO-key International on 17 of the 17 factors compared between the two stocks.

How does BIO-key International compare to Palo Alto Networks?

BIO-key International (NASDAQ:BKYI) and Palo Alto Networks (NASDAQ:PANW) are both technology companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Palo Alto Networks has a consensus target price of $392.38, indicating a potential upside of 4.62%. Given Palo Alto Networks' stronger consensus rating and higher probable upside, analysts plainly believe Palo Alto Networks is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Palo Alto Networks
0 Sell rating(s)
12 Hold rating(s)
38 Buy rating(s)
0 Strong Buy rating(s)
2.76

In the previous week, Palo Alto Networks had 23 more articles in the media than BIO-key International. MarketBeat recorded 32 mentions for Palo Alto Networks and 9 mentions for BIO-key International. Palo Alto Networks' average media sentiment score of 1.01 beat BIO-key International's score of 0.16 indicating that Palo Alto Networks is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Palo Alto Networks
21 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Palo Alto Networks has a net margin of 2.67% compared to BIO-key International's net margin of -50.01%. Palo Alto Networks' return on equity of 8.50% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Palo Alto Networks 2.67%8.50%4.35%

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 79.8% of Palo Alto Networks shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Comparatively, 1.4% of Palo Alto Networks shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

BIO-key International has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market. Comparatively, Palo Alto Networks has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

Palo Alto Networks has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Palo Alto Networks, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.70M0.62-$7.16M-$4.11N/A
Palo Alto Networks$11.48B26.72$307M$0.51735.37

Summary

Palo Alto Networks beats BIO-key International on 15 of the 16 factors compared between the two stocks.

Get BIO-key International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BKYI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BKYI vs. The Competition

Export
MetricBIO-key InternationalSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$4.05M$16.67B$29.85B$12.91B
Dividend YieldN/A3.42%2.76%19.59%
P/E Ratio-0.69143.3978.1825.26
Price / Sales0.601,269.77576.6475.17
Price / CashN/A46.5449.0152.75
Price / Book0.608.847.696.00
Net Income-$7.16M$429.53M$767.06M$380.56M
7 Day Performance62.07%-0.82%-3.65%-3.34%
1 Month Performance6.02%-0.93%-2.89%-5.89%
1 Year Performance-62.35%-0.01%160.77%-5.56%

BIO-key International Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BKYI
BIO-key International
0.9837 of 5 stars		$2.82
-3.1%		N/A-61.1%$4.05M$6.70MN/A42
AUID
authID
1.3059 of 5 stars		$0.38
-2.9%		N/A-88.2%$6.29M$2.04MN/A46
BTQ
BTQ Technologies
N/A$3.07
-5.9%		N/A-65.3%$0.00N/AN/A35
MSFT
Microsoft
4.915 of 5 stars		$527.75
-0.3%		$578.73
+9.7%		+3.9%$3.92T$331.84B29.38223,000
ORCL
Oracle
4.9908 of 5 stars		$144.29
-0.3%		$251.72
+74.5%		-56.4%$435.01B$67.36B22.55141,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BKYI) was last updated on 10/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
100% overnight gains?
Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...
The Oxford Club | Sponsoredtc pixel